Video

Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL

Author(s):

Manali Kamdar, MD,Matthew A. Lunning, DO, FACP

Dr Lunning, DO, FACP, shares his impressions on the toxicity profile of axi-cel and liso-cel, and how he approaches treatment decision making for patients with relapsed-refractory (R/R) large B-cell lymphoma (LBCL).

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
The Role of the Multidisciplinary Care Team in the Diagnosis and Management of Acute Hepatic Porphyria
Video

The Role of the Multidisciplinary Care Team in the Diagnosis and Management of Acute Hepatic Porphyria

Apr 28th 2025 - Apr 29th 2026

online-activity
View More
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Apr 28th 2025 - Apr 29th 2026

online-activity
View More
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 24th 2025 - Apr 25th 2026

online-activity
View More
Related Content
The top 5 OncLive videos of the week cover insights in chronic lymphocytic leukemia, ovarian cancer, multiple myeloma, and large B-cell lymphoma.
April 27th 2025

Five Under 5: Top Oncology Videos for the Week of 4/20

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Acute Lymphoblastic Leukemia | Image Credit: © Nittaya – stock.adobe.com
April 23rd 2025

Inati-Cel Induces High CR and MRD Negativity Rates in CD19+ R/R B-ALL

Matthew Lunning, DO, FACP
October 30th 2023

Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

María-Victoria Mateos, MD, PhD, consultant physician, Hematology Department, associate professor, medicine, University of Salamanca
April 18th 2025

Cilta-Cel Emerges as a SOC in Lenalidomide-Refractory Multiple Myeloma

Mantle Cell Lymphoma | Image Credit: © Tatiana Shepeleva – stock.adobe.com
April 18th 2025

LV20.19 CAR T-Cell Therapy Yields 100% ORR and Manageable Toxicity in R/R MCL